Προσφορά για την προμήθεια Bortezomib, Etoposide και Liposome Doxorubicin, Αρ. Διαγωνισμού: Φ.Υ.Υ. 1/2026 (ΟAΥ), Αρ.Φακ. Φ.Υ.Υ.13.25.02.08.268
can-standardContract or concession award notice – standard regime00341303-2026DIDepartment of Insolvency
Estimated value€357,316
Deadline—
Competition00 participants
Lots33 lots
Keep momentum on this opportunity
Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.
- Save and reuse search filters
- Track opportunities as pursuits
- Get notified when new notices match
Quick actions
Keep this notice in a shortlist so you can return to it without starting a bid.
Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.
Key information
Identifier
Contract type
—
Deadline
—
CPV codes
33652100 - Antineoplastic agents
Status
Awarded
Notice type
can-standardContract or concession award notice – standard regime
Source
Estimated value
€357,316
Publication date
18 May 2026, 22:00
Overview
Προμήθεια Bortezomib, Etoposide και Liposome Doxorubicin, Αρ. Διαγωνισμού: Φ.Υ.Υ. 1/2026 (ΟAΥ), Αρ.Φακ. Φ.Υ.Υ.13.25.02.08.268
Ο διαγωνισμός διενεργήθηκε από την Διεύθυνση Αγορών και Προμηθειών του Υπουργείου Υγείας για τον Οργανισμό Ασφάλισης Υγείας
Lots3
Documentation0
The source system does not support document syncing.
Award criteria0
No procedure-level award criteria recorded.